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Abstract 
 
Clonorchiasis is a parasitic infection caused by food borne trematode, Clonorchis sinensis that is 
mainly prevalent in Asian countries, including South Korea, China, northern Vietnam, Japan, as well as 
far-eastern Russia, in which over 35 million people are the casualties. Clonorchiasis is characterized by 
the development of hepatic fibrosis. Upon chronic liver injury following the C. sinensis infection, hepatic 
fibrosis develops into cholangiocarcinoma with a concomitant genetic and epigenetic mutations. 
Cholangiocarcinoma represents important clinical manifestation of C. sinensis infection and causes high 
rate of morbidity. TGF- β/Smad signalling is known to initiate hepatic fibrosis following the hepatic 
injury. However, little is known about the role of TGF- β/Smad signalling during C. sinensis induced 
hepatic injury and the underlying contribution of TGF- β/Smad signalling in the development of 
cholangicarcinoma. The expression dynamic of TGF-β/Smad signalling and their role in the development 
of hepatic fibrosis in C. sinensis infected BALB/c mice have been investigated. Concomitantly but 
irrespective to C. sinensis infection, the role of hepatic epithelial TGF-β during hepatic fibrosis and the 
development of cholangiocarcinoma arising from hepatic epithelial cells have also been dissected. Both 
findings will be reviewed in this paper. Thereby, the link between TGF-β/Smad signalling, hepatic fibrosis 
during C sinensis infection, and cholangiocarcinoma could be drawn clearly.  
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INTRODUCTION  
 
Clonorchiasis is a parasitic infection caused 
by food borne trematode, Clonorchis sinensis. C. 
sinensis infection is mainly prevalent in Asian 
countries, including South Korea, China, northern 
Vietnam, Japan, as well as far-eastern Russia, in 
which over 35 million people are the casualties 
(Qian, et al., 2016). People become sick after eating 
raw or insufficiently cooked aquatic product 
containing metacercariae or after drinking the 
contaminated water. In the duodenum, the ingested 
metacercariae will develop into adult worm by the 
stimulation of gastric juice and migrate to 
intrahepatic bile duct (Hong, et al., 2012). Following 
the migration of the adult worms into intrahepatic 
bile duct, transient hepatic fibrosis is developed at 7 
days after infection. Hepatic fibrosis is a wound 
healing response against hepatic injury by the adult 
worms and characterized by an excessive 
accumulation of extracellular matrix (ECM) 
component, such as collagen and fibronectin (Wynn, 
et al., 2012).  
Patients normally experience mild symptoms 
during transient hepatic fibrosis, such as diarrhea 
and abdominal pain.The moderate amounts of adult 
worms (101-1000) can cause loss of appetite, rash, 
edema, night blindness, swollen abdomen, and 
enlargement of the liver. Eventually, the acute 
symptoms will abate and the liver architectures is 
restored to normal following the treatment with 
praziquantel. However, if the infection persists and 
reach chronic stage, as in the case of C. sinensis 
infection,  in which  adult worm could reside in the  
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bile duct for 20-40 years, the liver become 
malfunction. As the consequence of progressive 
fibrosis, there will be liver obstruction, which could 
develop into cholangiocarcinoma. Cholangio-
carcinoma is a malignant tumor that arises from 
hepatic bile dutcs and represents important clinical 
manifestation of C. sinensis infection. The 
International Agency for Research on Cancer 
(IARC) classifies C. sinensis as a probable 
carcinogen (group 2A). Nevertheless, the mechanism 
of C. sinensis carcinogenesis remains elusive (Keiser 
& Utzinger, 2009; Wu, et al., 2012).  
 
THE ROLE OF CYTOKINE(S) DURING 
HEPATIC FIBROSIS 
The role of cytokine system is highly 
appreciated to regulate liver fibrosis during C. 
sinensis infection and eventually control the 
development of cholangiocarcinoma. In fact, many 
excretory/secretory proteins from C. sinensis 
tegument (ESPs) including secretory phospholipase 
A (2) (CsPLA2), lysophospholipase (CslysoPLA), 
fructose-1, 6-bisphosphatase (CsFBPase) and Fe 
heavy chain protein (CsFHC) have been reported to 
induce the production of regulatory cytokine TGF- β 
(Hu, et al., 2009). The TGF- β, especially TGF- β1 is 
acknowledged as a critical fibrogenic stimulus. 
During chronic hepatic injury, inflammatory cells 
secreting inflammatory mediators, including TGF- β, 
are recruited in the area of tissue injury. TGF- β 
enhances the activation of the hepatic stellate cells 
(HSCs) or pericytes. The HCSs will then 
differentiate from vitamin A storing cells into 
myofibroblasts (MFs) expressing alpha smooth 
muscle actin (-SMA). The MFs is the primary 
source of fibrogenic population in the liver and 
secrete an excessive amount of ECM (Mao, et al., 
2015; Yan, et al., 2015). In addition to HSCs 
activation, TGF- β also mediate trans-differentiation 
of hepatic epithelial cells (hepatocytes and 
cholangiocytes) into MFs through biological process 
known as EMT (epithelial mesenchymal transition). 
EMT allows a closely attached epithelial cells with 
apical-basal polarity to migrate and acquire a 
mesenchymal cell phenotype (migratory capacity, 
invasiveness, resistance to apoptosis, and production 
of ECM). EMT has been associated with wide range 
of biological processes, not only tissue regeneration 
and fibrosis but also with embryonic development 
and cancer progression (Hernandez-Gea and 
Friedman, 2011). 
Transforming growth factor-β (TGF-β) 
signalling is important in the regulation of cell 
growth, differentiation, and development in a wide 
range of biological process (Warmflash, et al., 
2012). TGF-β has been implicated in tumour 
progression, however the function and utility of 
TGF-β are very complex and highly dependent on 
the cellular context it is involved with. Of note, 
TGF-β is reported to exhibit both tumour 
suppression and promotion in temporally and 
spatially different level (Padua and Massague, 
2009). 
In general, TGF-β is secreted by variety of 
cell types in three major isoforms, namely TGF-β1, 
TGF-β2, and TGF-β3.  The most important 
fibrogenic stimulus, TGF- β1, is stored as an 
inactivated homo- or hetero-dimers of protein bound 
to a latency-associated protein and activated through 
proteolytic cleavage by endoproteases. TGF-β 
mediates signalling through serine/threonine kinase, 
TGF-β receptor type I (TβRI) and TGF-β receptor 
type II (TβRII). Initially, TGF-β will bind to TβRII. 
Thereafter, TβRII will dimerizes with TβRI and bind 
to Smad2 and Smad 3 transcription factors. The 
TβR/Smad complex becomes phosphorylated and is 
released into the cytosol, where it will associate with 
Smad4. The resulting complex will translocate into 
the nucleus and regulate gene transcription, 
including ECMs. The TGF-β/Smad signalling can be 
inhibited endogenously by Smad6/7, which prevents 
the binding of Smad2/3 to the receptor. In regulating 
various biological process, TGF-β also elicits non-
canonical signalling response through signalling 
crosstalk with Ras and MAP kinase, Wnt signalling, 
and Notch signalling, which adding the complexity 
of TGF-β signalling (Minoo and Li, 2010; Remi, et 
al., 2004; Xu, et al., 2009). 
Of note, very little is known about the role of 
TGF-β/Smad signalling during hepatic fibrosis 
caused by C. sinensis. In their recent publication, 
Yan and co-workers (2015) investigated the 
expression dynamic of TGF-β/Smad signalling and 
analysed their possible role in the development of 
hepatic fibrosis in C. sinensis infected BALB/c mice. 
Concomitantly but irrespective to C. sinensis 
infection, Mu and co-workers (2016) used a TβRII 
knockout  mice to show the role of epithelial  TGF-β 
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during hepatic fibrosis and the development of 
cholangiocarcinoma arising from hepatic epithelial 
cells.  
 
The expression dynamics of TGF-β/Smad 
signalling in the development of hepatic 
fibrosis caused by C. sinensis 
The study by Yan and co-workers (2015) 
highlights the involvement of TGF-β/Smad 
signalling in the development of hepatic fibrosis 
caused by C. sinensis. The authors used female 
BALB/c mice as an animal model for developing 
hepatic fibrosis by per-oral administration of C. 
sinensis metacercariae. Following the infection of 
mice with C. sinensis metacercariae, mice could 
develop a moderate periductal fibrosis at 4 weeks 
post infection (p.i). Meanwhile, the massive 
deposition of collagen was observed from the portal 
areas to liver lobules after 8 weeks p.i using 
hematoxylin and eosin as well as Masson’s 
trichrome staining. The development of hepatic 
fibrosis was further validated by the expression of 
pro-fibrotic molecular markers during C. sinensis 
infection. The total mRNA was extracted from liver 
tissue. Using qPCR, the authors showed that the 
mRNA level of -SMA and collagen 1 (Col1a) 
were significantly increased from 4 weeks p.i to 16 
weeks p.i compare to control. In order to investigate 
the activation of TGF-β/Smad signalling during 
hepatic fibrosis induced by C. sinensis infection, the 
authors examined the mRNA and protein expression 
within TGF-β/Smad signalling pathway. As 
expected, the hepatic fibrosis mice exhibited high 
expression of TGF-β1, Smad2/3, TβRI, and TβRII 
mRNA. This result implicates the involvement of 
TGF-β/Smad signalling in hepatic fibrosis following 
the C. sinensis infection (Fig. 1).  
Several studies have been conducted and 
confirmed the role of TGF-β/Smad signalling in 
parasite-induced hepatic fibrosis. The studies were 
conducted using various parasites, including the 
metacercariae of Echinococcus multicularis, 
Schistosoma japonicum, and Schistosoma mansoni’s 
soluble egg antigens. The authors generally reported 
similar finding and pinpointed the role of TGF-
β/Smad signalling in the activation of HSCs as the 
initial step of hepatic fibrosis following the parasitic 
infection. The expression of TGF-β1 and Smad2/3 
were markedly high in the hepatic areas close to and 
distant from parasitic lesions, while the expression 
of Smad7 was essentially down-regulated (Barros, et 
al., 2014; Chen, et al., 2013; Wang, et al., 2013).  
The expression dynamic of Smad proteins 
was shown by Yan and co-workers (2013). Using 
qPCR analysis, the mRNA level of Smad4, Smad2, 
and Smad7 were examined. The expression of 
Smad4 was increased at 4 weeks p.i, however as the 
hepatic fibrosis developed, the expression of Smad4 
was markedly decreased, suggesting that the effect 
of Smad4 might occur at early and middle stage of 
hepatic fibrosis. Nevertheless, the expression of 
Smad7 was negatively correlated with the expression 
level of Smad2 during hepatic fibrosis, which further 
confirmed contribution of TGF-β/Smad signalling. 
 
 
Figure 1. The involvement of TGF-β/Smad signalling during C. sinensis infection. The TGF-β/Smad signalling is 
activated during the early stage of hepatic fibrosis developed after C. sinensis infection. 
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The cellular compartment specific dependent 
contribution of TGF-β/Smad signalling in 
hepatic tumorigenesis 
In the liver, TGF-β can be produced by 
infiltrated inflammatory cells and hepatic 
parenchyma cells, including epithelial cells 
(hepatocytes and cholangiocytes), endothelial cells, 
as well as resident non-parenchymal cells (HSCs and 
Kupffer cells). Moreover, the regulatory output of 
TGF-β/Smad signalling is known to be temporally 
and spatially different depending on the cellular 
context, thereby different cellular compartments of 
TGF-β could exhibit different effect. Mu and co-
workers (2016) attempted to dissect the role of 
hepatic epithelial TGF-β during hepatic fibrosis and 
the underlying cholangiocarcinoma.  
In order to dissect the role of hepatic 
epithelial TGF-β, the authors used double transgenic 
mice expressing floxed TβRII and Albumin-Cre to 
knockout the TGF-β signalling in the hepatic 
epithelial (Mu, et al., 2016). They also made use of 
toxicity-induced fibrosis (carbon tetratchloride/CCl4 
injections in mice) and cholestatic hepatic fibrosis 
(common bile duct ligation and Mdr2 knockout 
mice) to develop chronic hepatic fibrosis in mice. 
Using chronic hepatic mice model only, they showed 
that TGF-β signalling was activated in both the 
epithelial and mesenchymal cell compartments of 
chronically injured liver. Conversely, using double 
transgenic expressing floxed TβRII and Albumin-
Cre in chronically injured mice, they found out that 
there was no significant difference in the status of 
hepatic fibrosis compare to control mouse, as shown 
by the expression of pro-fibrotic molecular markers. 
However, they showed the markedly elevated 
expression of keratin. This data suggests that 
epithelial TGF-β does not contribute to hepatic 
fibrosis but rather control the expansion of 
cholangiocytes. Furthermore, TGF-β from other 
cellular compartments other than hepatic epithelial 
cells also contribute to parasite-induced hepatic 
fibrosis, including C. sinensis induced hepatic 
fibrosis. 
The authors observed a significant role of 
TβRII in tumorigenesis caused by the phosphatase 
and tensin homolog deleted on chromosome 10 
(PTEN) loss.  PTEN is a tumor suppressor gene that 
antagonizes and suppresses cell survival as well as 
cell proliferation (Yin and Shen, 2008). Using triple 
transgenic mouse where Albumin-Cre drives the loss 
of TβRII and PTEN simultaneously in hepatic 
epithelial cells, they showed that mice deficient of 
both TβRII and PTEN developed tumours and die at 
5-7 months of age, while the PTEN deficient mice 
were tumour free at the similar age. The tumours 
were keratin positive and exhibited high expression 
of cholangiocyte and cholangiocarcinoma markers, 
suggesting that TβRII and PTEN loss induce 
cholangiocarcinoma in chronically injured mice.  
It was not very clear whether the 
cholangiocarcinoma developed in mice is 
hepatocytes or cholangiocytes origin, because the 
deletion strategy using Albumin-Cre affected both 
hepatocytes and cholangiocytes. Thereby, to 
distinguish between TGF-β signalling in hepatocytes 
and cholangiocytes, the authors used cell type 
specific ablation strategies to knockout TβRII. In 
order to develop cholangiocytes specific ablation, 
they made use of two different mice strains, Prom-1-
CreERT2 with floxed TβRII and PTEN as well as 
K19-CreERT with floxed TβRII and PTEN. Both 
prominin and keratin 19 are surface markers for 
cholangiocytes. Prior to conditional deletion, all 
mice were put in 3,5-diethylcarbonyl-1,4-
dihydrocollidine (DDC) to induce cholestatic hepatic 
injury. Meanwhile, for inducing specific ablation in 
hepatocytes, the authors used double transgenic 
TβRII and PTEN floxed mice and AAV8-TBG-Cre 
virus infection. Interestingly, after being sacrificed, 
both mice models were shown to develop the 
characteristics of cholangiocarcinoma irrespective to 
the cell compartment origin. Moreover, by co-
labelling the Cre with GFP, they demonstrated that 
the developed cholangiocarcinoma in cholangiocytes 
specific deletion mice, had hepatocytes origin. This 
result suggests that the loss of TβRII and PTEN in 
hepatic epithelial cells will give rise to proliferation 
of cholangiocytes cells derived from hepatocytes 
cells, which lead to the development of 
cholangiocarcinoma.  
 
CONCLUDING REMARK 
Of note, the contribution of TGF-β/Smad 
signalling during chronic hepatic fibrosis and C. 
sinensis induced hepatic fibrosis have been validated 
through the study from Yan and co-workers (2015) 
as well as Mu and co-workers (2016). During 
hepatic injury TGF-β proteins secreted from various 
cells in the liver as well as infiltrated inflammatory 
cells, inhibit hepatocyte proliferation, induce 
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hepatocyte apoptosis, and activate HSC to 
differentiate into MFs. Through canonical Smad 
signalling, TGF-β proteins regulate gene 
transcription of ECMs as well as induce the 
production of pro-fibrosis molecular markers and 
ECM in MFs. Hepatic fibrosis is developed as the 
excessive amount of ECM is built up in the liver. 
However, not all the cells in the liver contribute to 
the development of hepatic fibrosis following the 
chronic hepatic injury. Hepatic epithelial TGF-β 
does not contribute to hepatic fibrosis (Mu, et al., 
2016), suggesting the cellular compartment specific 
dependent contribution of TGF-β/Smad signalling. 
Accordingly, the identification of major cellular 
compartment that produces TGF-β/Smad signalling 
induced hepatic fibrosis is of importance, especially 
in the context of C. sinensis induced hepatic fibrosis. 
Hepatic fibrosis is a major symptom of 
Clonorchiasis, which affects 35 million people 
worldwide. Novel treatment could be established 
using inhibitor of TGF-β, which target specific 
cellular compartment in the liver to improve the 
therapeutic outcome.  
The loss of hepatic epithelial TβRII with the 
accompanying loss of tumour suppressor gene is 
enough to induce cholangiocarcinoma arising from 
chronic hepatic fibrosis (Mu, et al., 2016) (Fig. 2). 
TGF-β has dual role in tumorigenesis, as tumour 
suppressor and promoter. However, mutation in 
tumour suppressor gene may switch tumour 
suppressor effect of TGF-β into tumour promoter, as 
shown in the dynamic disposition of hepatic fibrosis 
into cholangiocarcinoma. In fact, the latest study 
from Ong and co-workers (2012) support this notion. 
The whole exome sequencing of eight liver 
trematode Opisthorchis viverrini related 
cholangiocarcinoma samples showed the somatic 
mutation in smad4 gene, which concomitant with 
mutation in tumour suppressor gene Tp53 and KRAS 
(Ong, et al., 2012). The inactivating mutation of the 
core element in TGF-β/smad signalling is tumour 
inherent mechanism to escape from tumour 
suppressor effect of TGF-β/smad signalling. Thus, 
allowing tumour cells to acquire proliferative and 
invasive features.  
The future research that focus on the 
generation of cholangiocarcinoma from C. sinensis 
induced hepatic fibrosis is certainly needed, 
considering the high mortality rate related to 
cholangiocarcinoma. The novel findings by Ong and 
co-workers (2012) as well as Mu and co-workers 
(2015) should be a starting point for further 
elucidating the role of TGF-β/smad signalling in the 
development of cholangiocarcinoma arising from C. 
sinensis induced hepatic fibrosis. 
 
 
 
 
Figure 2. The duality of TGF-β is switched into tumour promoter following the concomitant loss of tumour 
supressor gene during chronic hepatic fibrosis. 
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